Growth hormone study for adults with Prader-Willi syndrome
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether growth hormone treatment is safe and helpful for adults who have Prader-Willi syndrome. You might be considered if your diagnosis is confirmed and certain health risks—like diabetes and sleep breathing problems—are under control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic, confirmed diagnosis of Prader-Willi syndrome
- You are willing and able to cooperate with study visits and instructions
- You are not pregnant and can follow pregnancy testing rules (if applicable)
- Your diabetes is well controlled (HbA1c must not be above 8%)
- You do not have untreated sleep apnea and no significant upper-airway blockage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called BMB-101 to see if it can help control extreme hunger in adults with Prader-Willi Syndrome. It aims to improve safety and quality of life.
This trial tests an investigational drug called CSTI-500 for people with Prader-Willi syndrome who are in the hyperphagia (constant hunger) phase. It aims to see if the drug can improve behavior and reduce overeating. You and your caregiver will need to visit the clinic regularly and answer questions about symptoms.
This trial studies whether taking prebiotics and probiotics can help children with Prader-Willi syndrome manage obesity. It’s testing a gut-focused approach to weight control over the study period.
This trial tests a medication called pitolisant to see if it helps reduce excessive daytime sleepiness in people with Prader-Willi syndrome. You or your loved one may be able to join if they have a confirmed diagnosis and a caregiver who can regularly help with study tasks.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
Hear when a new Prader-Willi Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.